NLRP3 and Nephropathy: Zhao et al. demonstrated that NLRP3 and ASC expressions were significantly reduced after treatment with Bay 11-7082 compared to placebo-treated mice that had decreased proteinuria, blood urea nitrogen, resulting in dramatically attenuated kidney damage.